About this trial
This study is a single-center, randomized, open-label, controlled, endpoint-blinded study to assess the effect of off-script diagnosis \& differential diagnosis (D\&D) training in improving the residents' knowledge of acute ischemic stroke in China. The investigators will enroll 22 residents and assess the score of mASMaQ 30 days after randomization.
Eligibility criteria
Qualifiers
Residents (physicians in postgraduate training).
Currently in neurology wards
Managing acute ischemic stroke (AIS) patients, defined as: 1)Time from onset to randomization ≤ 2 weeks; 2) If onset time is unknown, the last known well time is considered the onset time.
Signed informed consent
Disqualifiers
Managing asymptomatic ischemic stroke patients.
Residents who are currently participating or have participated in another interventional ischemic stroke training program within the past 3 months.
Trial design
Treatments tested in this trial
- Off-script diagnosis & differential diagnosis (D&D) training